Drug
Tetanus Immune Globulin
Tetanus Immune Globulin: highest development phase Post-Market, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tetanus Immune Globulin (Human) NCT00437671 | Post-Market | Tetanus |
Latest
No recent events.
Follow Tetanus Immune Globulin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.